Oncology & Cancer

Critical oncology trial data remains hidden

Despite a commitment from the pharmaceutical industry in 2014 to improve data transparency, more than half of the clinical trials that led to the United States Food and Drug Administration approving anticancer medicines over ...

Medications

Treating tough tumors by exploiting their iron 'addiction'

Researchers at the University of California, San Francisco, have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account ...

Medications

Simplified antibiotic may set the stage for antitumor treatments

Garden soil houses a variety of bacteria and their natural byproducts—including one that may help halt tumor growth. Lankacidins are molecules that can be isolated from Strepomyces rochei, a common bacterium in soil. In ...

page 5 from 15